ArticleCancers2020

Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer.

Veronica Ghini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.